Literature DB >> 15051814

The neurobiology of selenium: lessons from transgenic mice.

Ulrich Schweizer1, Lutz Schomburg, Nicolai E Savaskan.   

Abstract

The brain represents a privileged organ with respect to selenium (Se) supply and retention. It contains high amounts of this essential trace element, which is efficiently retained even in conditions of Se deficiency. Accordingly, no severe neurological phenotype has been reported for animals exposed to Se-depleted diets. They are, however, more susceptible to neuropathological challenges. Recently, gene disruption experiments supported a pivotal role for different selenoproteins in brain function. Using these and other transgenic models, longstanding questions concerning the preferential supply of Se to the brain and the hierarchy among the different selenoproteins are readdressed. Given that genes for at least 25 selenoproteins have been identified in the human genome, and most of these are expressed in the brain, their specific roles for normal brain function and neurological diseases remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051814     DOI: 10.1093/jn/134.4.707

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  24 in total

1.  Selenium level and cognitive function in rural elderly Chinese.

Authors:  Sujuan Gao; Yinlong Jin; Kathleen S Hall; Chaoke Liang; Frederick W Unverzagt; Rongdi Ji; Jill R Murrell; Jingxiang Cao; Jianzhao Shen; Feng Ma; Janetta Matesan; Bo Ying; Yibin Cheng; Jianchao Bian; Ping Li; Hugh C Hendrie
Journal:  Am J Epidemiol       Date:  2007-01-31       Impact factor: 4.897

2.  Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed.

Authors:  Avner Shahar; Kushang V Patel; Richard D Semba; Stefania Bandinelli; Danit R Shahar; Louigi Ferrucci; Jack M Guralnik
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

Review 3.  On elongation factor eEFSec, its role and mechanism during selenium incorporation into nascent selenoproteins.

Authors:  Miljan Simonović; Anupama K Puppala
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-17       Impact factor: 3.770

4.  Neuronal and ependymal expression of selenoprotein P in the human brain.

Authors:  M Scharpf; U Schweizer; T Arzberger; W Roggendorf; L Schomburg; J Köhrle
Journal:  J Neural Transm (Vienna)       Date:  2007-01-25       Impact factor: 3.575

5.  Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply.

Authors:  Ulrich Schweizer; Florian Streckfuss; Paco Pelt; Bradley A Carlson; Dolph L Hatfield; Josef Köhrle; Lutz Schomburg
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 6.  Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements.

Authors:  Mustafa Nazıroğlu; Vedat Ali Yürekli
Journal:  Cell Mol Neurobiol       Date:  2013-04-14       Impact factor: 5.046

7.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 8.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

Review 9.  The syndrome of inherited partial SBP2 deficiency in humans.

Authors:  Alexandra M Dumitrescu; Caterina Di Cosmo; Xiao-Hui Liao; Roy E Weiss; Samuel Refetoff
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

10.  Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration.

Authors:  Eva K Wirth; Marcus Conrad; Jochen Winterer; Christian Wozny; Bradley A Carlson; Stephan Roth; Dietmar Schmitz; Georg W Bornkamm; Vincenzo Coppola; Lino Tessarollo; Lutz Schomburg; Josef Köhrle; Dolph L Hatfield; Ulrich Schweizer
Journal:  FASEB J       Date:  2009-11-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.